Funding, M&A, exec moves and hiring — matched to your market, with the people to call.See plans →
Legend Biotech Appoints Alan Bash As Interim Chief Executive Officer
PUBLIC · LEGNJul 27, 2026•14 days ago
Position
Chief Executive Officer
Company
Legend Biotech
Description
Legend Biotech has announced the resignation of Ying Huang, Ph.D., as Chief Executive Officer, effective July 24, 2026. Alan Bash has been appointed as the Interim Chief Executive Officer while the Board conducts a search for a permanent successor.
Related People
Suggested for you
Executive Insights
Based on hiring dataNew executive impact window
87% of new executives make significant technology decisions within first 100 days
Budget influence
C-level executives control 73% of technology spending decisions
Transformation catalyst
65% of new senior hires launch digital transformation initiatives
Vendor review timeline
New executives typically review existing vendors within 6 months